
Rocket Pharmaceuticals, Inc.
USD2.96
+0.04 (+1.20%)
CEO
Gaurav D. Shah
IPO Date
2015-02-18
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$2.93
Prev. Close
$2.92
Day Low
$2.92
Day High
$3.04
52W Low
$2.40
52W High
$5.45
Market Cap
$0.32B
Volume
1.28M
| 2 Mar 2026 |
| Goldman Sachs |
| Sell |
| Sell |
| maintain |
| 27 Feb 2026 | Cantor Fitzgerald | Overweight | Overweight | maintain |
| 18 Nov 2025 | JP Morgan | Overweight | Underweight | downgrade |
| 18 Nov 2025 | B of A Securities | Buy | Buy | maintain |
| 14 Oct 2025 | Chardan Capital | Buy | Buy | maintain |
| 3 Oct 2025 | Leerink Partners | Market Perform | Market Perform | maintain |
| 20 Aug 2025 | B of A Securities | Neutral | Buy | upgrade |